The content of CTCs with phenotype CD87+, CD276+, CD87+CD117+, CD276+CD117+, EGF+SOX2+, CD87+SOX2+, and CD276+SOX2+ was as high as in the general group of patients with SCLC. This evidence concerns the gene SOX2 and small cell lung carcinoma.